To assess whether a similar regulation occurs in human tumor tissues after sunitinib-treatment, a set of primary RCC tissues was subjected to ICAM-1 expression analysis by qPCR and immunohistochemistry. The gene discussed is ICAM1; the disease is renal cell carcinoma.